WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

医会宝，致力于专业的医学知识交流服务平台，包括大咖直播、线上会议直播、手术直播等，涵盖执业医师关注的医学会议服务、线上医学课程、热点医学资讯，构建医生个人专属名片，医学直播提供在线快速问答交流医学会议在线报名、海量医学会议线上直播，会议智能扫码签到，全方位学术会议服务，打造智慧医疗会议服务体系

南京岚煜生物科技有限公司成立于2016年，是一家体外诊断试剂及仪器的研发、生产和销售的生物公司，其中研发人员占比60%左右，核心研发人员均来自国内外知名科研机构及生物医药公司。

佛山市轩科医疗科技有限公司主营：爱尔博ERBE、狼牌R.WOLF、柯惠COVIDIEN无线超声刀头等全球顶尖品牌微创手术内窥镜及其器械配件和宫腹腔镜手术耗材和手术室售后解决方案。

Lifeisknowingtruth.

吉宣生物河北吉宣生物科技有限公司由上海吉宣生物科技有限公司于2016年投资成立于河北省会石家庄，是一家集体外检测试剂及检测设备的研发、生产和销售为一体的高新技术企业，其生产厂房位于石家庄经济技术开发区，业务部门设立于北京，研发和部分生产设立于上海。其母公司——上海吉宣生物科技有限公司，是一家从事生物科技专业领域技术研发的科研型公司。

作为世界上最权威的科技商业媒体之一，MITTechnologyReview于1899年在美国麻省理工学院创刊，至今已经走过121年，为全世界超过300万专业人士及商业领袖提供前瞻性的资讯和独到深入的行业趋势分析。